Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.97 USD | -0.44% | +0.11% | -20.20% |
Mar. 01 | Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022. | CI |
Feb. 26 | Transcript : Theravance Biopharma, Inc., Q4 2023 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.20% | 432M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Theravance Biopharma, Inc. - Nasdaq
- News Theravance Biopharma, Inc.
- Theravance Biopharma : Baird Adjusts Theravance Biopharma PT to $7 From $10, Maintains Neutral Rating